KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Precigen (PGEN) Invested Capital (2016 - 2025)

Precigen (PGEN) has disclosed Invested Capital for 13 consecutive years, with $134.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital rose 143.35% to $134.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was $134.8 million, a 143.35% increase, with the full-year FY2024 number at $38.5 million, down 67.5% from a year prior.
  • Invested Capital was $134.8 million for Q3 2025 at Precigen, up from -$36.8 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $349.3 million in Q1 2021 to a low of -$36.8 million in Q2 2025.
  • A 5-year average of $155.7 million and a median of $147.7 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: soared 198.65% in 2023, then plummeted 185.2% in 2025.
  • Precigen's Invested Capital stood at $287.3 million in 2021, then crashed by 41.01% to $169.5 million in 2022, then crashed by 30.08% to $118.5 million in 2023, then plummeted by 67.5% to $38.5 million in 2024, then skyrocketed by 249.9% to $134.8 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Invested Capital are $134.8 million (Q3 2025), -$36.8 million (Q2 2025), and -$14.1 million (Q1 2025).